Danaher Corp (DHR):企業の財務・戦略的SWOT分析

◆英語タイトル:Danaher Corp (DHR) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME575FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:69
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥35,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥52,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Danaher Corp (DHR) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Danaher Corp (Danaher) designs, manufactures and markets medical, professional, commercial and industrial products and services. It offers a wide range of testing instruments, communications solutions, water quality systems, medical diagnostics solutions, life science research tools, professional microscopes, product identification solutions, automation solutions and sensors and controls solutions. The company operates manufacturing, sales, distribution, service and administrative facilities in Europe, Australia, Asia and the Americas. The company distributes its products to its customers across the Americas; Europe, Middle East, Africa and Asia-Pacific through direct sales personnel and independent distributors. Danaher is headquartered in Washington DC, the US.

Danaher Corp Key Recent Developments

Apr 13,2021: Danaher Provides Update On First Quarter 2021 Financial Performance
Mar 25,2021: Danaher Schedules First Quarter 2021 Earnings Conference Call
Jan 28,2021: Danaher reports fourth quarter and full year 2020 results
Dec 21,2020: Danaher announces executive appointment – 2020
Dec 14,2020: Danaher announces the appointment of Jennifer L. Honeycutt to the Executive Vice President

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Danaher Corp – Key Facts
Danaher Corp – Key Employees
Danaher Corp – Key Employee Biographies
Danaher Corp – Major Products and Services
Danaher Corp – History
Danaher Corp – Company Statement
Danaher Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Business Unit
Section 2 – Company Analysis
Company Overview
Danaher Corp – Business Description
Product Category: Analytical and Physical Instrumentation
Performance
Product Category: Product Identification
Performance
Product Category: Research and Medical Products
Performance
Product Category: Diagnostics
Overview
Performance
Product Category: Environmental & Applied Solutions
Overview
Performance
Product Category: Life Sciences
Overview
Performance
Geographical Segment: All other (each country individually less than 5% of total sales)
Performance
Geographical Segment: China
Performance
Geographical Segment: Germany
Performance
Geographical Segment: United States
Performance
R&D Overview
Danaher Corp – Corporate Strategy
Danaher Corp – SWOT Analysis
SWOT Analysis – Overview
Danaher Corp – Strengths
Danaher Corp – Weaknesses
Danaher Corp – Opportunities
Danaher Corp – Threats
Danaher Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences, Oil & Gas Financial Deals and Alliances
Danaher Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Danaher Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Danaher Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 13, 2021: Danaher Provides Update On First Quarter 2021 Financial Performance
Mar 25, 2021: Danaher Schedules First Quarter 2021 Earnings Conference Call
Jan 28, 2021: Danaher reports fourth quarter and full year 2020 results
Dec 21, 2020: Danaher announces executive appointment – 2020
Dec 14, 2020: Danaher announces the appointment of Jennifer L. Honeycutt to the Executive Vice President
Oct 22, 2020: Danaher reports third quarter 2020 results
Sep 01, 2020: Danaher appoints Rainer M. Blair as president And CEO
Jul 23, 2020: Danaher reports second quarter 2020 results
May 06, 2020: Danaher reports first quarter 2020 results
May 06, 2020: Danaher announces CEO Transition
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Danaher Corp, Key Facts
Danaher Corp, Key Employees
Danaher Corp, Key Employee Biographies
Danaher Corp, Major Products and Services
Danaher Corp, History
Danaher Corp, Other Locations
Danaher Corp, Subsidiaries
Danaher Corp, Business Unit
Danaher Corp, Key Competitors
Danaher Corp, Ratios based on current share price
Danaher Corp, Annual Ratios
Danaher Corp, Annual Ratios (Cont...1)
Danaher Corp, Annual Ratios (Cont...2)
Danaher Corp, Interim Ratios
Danaher Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Danaher Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Danaher Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Danaher Corp (DHR):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sartorius Stedim Biotech SA (DIM)-医療機器分野:企業M&A・提携分析
    Summary Sartorius Stedim Biotech SA (SSB) is a supplier of equipment and services to the biopharmaceutical companies. It offers integrated solutions covering filtration, fermentation, fluid management, purification and lab technologies. Its major products include laboratory balances, OEM weigh cells …
  • Lekoil Ltd (LEK):企業の財務・戦略的SWOT分析
    Summary Lekoil Ltd (Lekoil) is an oil and gas exploration and production company with interests in Nigeria and Namibia. The company owns oil and gas exploration and production properties such as Otakikpo marginal field, Nigeria Dahomey Basin OPL310 and Nigeria Dahomey Basin OPL 325 in Nigeria, and B …
  • Green Cross Cell Corp (031390):製薬・医療:M&Aディール及び事業提携情報
    Summary Green Cross Cell Corp (Green Cross Cell), a subsidiary of Green Cross Corp, is a provider of immunotherapeutics for the treatment of cancer. The company offers Immuncell-LC, an anti-cancer immune therapeutic that is derived from lymphocytes of cancer patient. It offers cryopreservation of co …
  • Haci Omer Sabanci Holding A.S. (SAHOL)-エネルギー分野:企業M&A・提携分析
    Summary Haci Omer Sabanci Holding A.S. (Sabanci) is an industrial and financial conglomerate. The company carries out banking, insurance, energy, retail, cement, insurance, automotive, tire and tire reinforcement materials businesses. The company has partnerships with various multinational business …
  • Madrigal Pharmaceuticals Inc (MDGL):製薬・医療:M&Aディール及び事業提携情報
    Summary Madrigal Pharmaceuticals Inc (Madrigal), formerly, Synta Pharmaceuticals Corp is a biopharmaceutical company focused on the development and commercialization of novel therapeutic candidates for the treatment of liver, cardiovascular and metabolic diseases. Its lead product candidate, MGL-319 …
  • Petroleo Brasileiro S.A. (Petrobras):戦略・SWOT・企業財務分析
    Petroleo Brasileiro S.A. (Petrobras) - Strategy, SWOT and Corporate Finance Report Summary Petroleo Brasileiro S.A. (Petrobras) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • H2O Retailing Corporation:企業の戦略・SWOT・財務情報
    H2O Retailing Corporation - Strategy, SWOT and Corporate Finance Report Summary H2O Retailing Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • GeNeuro SA (GNRO):製薬・医療:M&Aディール及び事業提携情報
    Summary GeNeuro SA (GeNeuro) is a clinical stage pharmaceutical company that manufactures therapeutic product pipeline for disorders of the nervous system. The company provides treatments against inflammatory and degenerative disorders associated with endogenous retroviruses. GeNeuro develops therap …
  • Entellus Medical Inc (ENTL):企業の財務・戦略的SWOT分析
    Summary Entellus Medical Inc (Entellus Medical) a subsidiary of Stryker Corp, operates as a medical device company that offers invasive products for the treatment of chronic sinusitis. The company’s products include multi sinus dilation system, surgical instruments, sinonasal suction and irrigation …
  • Toda Corporation:企業の戦略・SWOT・財務分析
    Toda Corporation - Strategy, SWOT and Corporate Finance Report Summary Toda Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • J. Front Retailing Co., Ltd.:戦略・SWOT・企業財務分析
    J. Front Retailing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary J. Front Retailing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • ZIL Ltd:企業の戦略・SWOT・財務分析
    ZIL Ltd - Strategy, SWOT and Corporate Finance Report Summary ZIL Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Bourbon Corporation:企業の戦略・SWOT・財務情報
    Bourbon Corporation - Strategy, SWOT and Corporate Finance Report Summary Bourbon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Cosmo Pharmaceuticals NV (COPN):企業の財務・戦略的SWOT分析
    Summary Cosmo Pharmaceuticals NV (Cosmo) is a pharmaceutical company that develops drugs for the treatment of gastro-intestinal diseases. The company develops its pharmaceutical products based on its multi matrix technology. Its proprietary clinical development pipeline intended for the treatment of …
  • Bloomberg LP:企業の戦略的SWOT分析
    Bloomberg LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Innovacell Biotechnologie AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Innovacell Biotechnologie AG (Innovacell) is a biotechnology company that focuses on the development of therapeutic products. The company offers personalized cell therapy products for the treatment of incontinence. It provides medical products such as ICES13 and ICEF15. Innovacell’s products …
  • Chesapeake Energy Corp (CHK):企業の財務・戦略的SWOT分析
    Chesapeake Energy Corp (CHK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Alacer Gold Corp:企業の戦略・SWOT・財務分析
    Alacer Gold Corp - Strategy, SWOT and Corporate Finance Report Summary Alacer Gold Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Pearson plc:企業の戦略・SWOT・財務情報
    Pearson plc - Strategy, SWOT and Corporate Finance Report Summary Pearson plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Assurant, Inc.:企業のM&A・事業提携・投資動向
    Assurant, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Assurant, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆